Skip to main content
Log in

Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Portal vein embolization (PVE) before extended right hepatectomy leads to an increase of the future liver remnant (FLR) volume, but predictive factors for sufficient hypertrophy are still unclear. The purpose of this study was to investigate parameters influencing the growth of FLR.

Methods

Patients undergoing PVE prior hepatic resection were evaluated. PVE was done using polyvinyl alcohol particles only. Volumetric analysis was performed before embolization and before hepatectomy. Success of PVE was determined as percental growth of the future liver remnant.

Results

Seventy-seven patients were included, and three cohorts were formed according to the hypertrophy of FLR. FLR increased from 448.2 ± 187 to 475.5 ± 191 in the poor, from 315.3 ± 86 to 469.1 ± 142 in the moderate, and from 283.4 ± 68 to 400.4 ± 110 in the good hypertrophy group. More cases of recanalization of the portal vein were observed in patients with poor hypertrophy (p = 0.016). Small FLR before PVE predict higher growth of the FLR (p = 0.006). Duration between PVE and surgery differed significantly: 22 (poor) vs. 32 (good) days (p = 0.040).

Discussion

No recanalization, small initial FLR and longer time were assessed with better FLR hypertrophy. More sufficient PVE techniques and postponed hepatectomy might improve the outcome. Small initial FLR should not be a disclosure for curative hepatectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Neuhaus P, Thelen A (2008) Radical surgery for right-sided Klatskin tumor. HPB (Oxford) 10(3):171–173. doi:10.1080/13651820801992708

    Article  CAS  Google Scholar 

  2. Arnold D, Rummeny EJ, Kirchner T, Ridwelski K, Oettle H, Hartmann JT, Moehler M, Holscher A, Lang H, Schlitt HJ, Neuhaus P (2009) Diagnosis and treatment of liver metastases from primary colorectal tumour]. Onkologie 32(Suppl 2):7–12

    Article  PubMed  Google Scholar 

  3. Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES, Tan SB (2012) Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 99(12):1622–1629

    Article  PubMed  Google Scholar 

  4. Helling TS (2006) Liver failure following partial hepatectomy. HPB (Oxford) 8(3):165–174

    Article  Google Scholar 

  5. van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, Jalan R, Saner FH (2008) Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28(6):767–780

    Article  PubMed  Google Scholar 

  6. Garcea G, Maddern GJ (2009) Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 16(2):145–155

    Article  PubMed  Google Scholar 

  7. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204(5):854–862. doi:10.1016/j.jamcollsurg.2006.12.032, discussion 862–854

    Article  PubMed  Google Scholar 

  8. de Meijer VE, Kalish BT, Puder M, Ijzermans JN (2010) Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97(9):1331–1339

    Article  PubMed  Google Scholar 

  9. McCall J, Koea J, Gunn K, Rodgers M, Jarvis J (2001) Liver resections in Auckland 1998–2001: mortality, morbidity and blood product use. N Z Med J 114(1144):516–519

    CAS  PubMed  Google Scholar 

  10. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57. doi:10.1097/SLA.0b013e31815f6e5b

    Article  PubMed  Google Scholar 

  11. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10(5):803–808

    Article  CAS  PubMed  Google Scholar 

  12. de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98(6):825–834. doi:10.1002/bjs.7456

    Article  PubMed  Google Scholar 

  13. Nishiyama Y, Yamamoto Y, Hino I, Satoh K, Wakabayashi H, Ohkawa M (2003) 99mTc galactosyl human serum albumin liver dynamic SPET for pre-operative assessment of hepatectomy in relation to percutaneous transhepatic portal embolization. Nucl Med Commun 24(7):809–817. doi:10.1097/01.mnm.0000080247.50447.34

    Article  CAS  PubMed  Google Scholar 

  14. Hirai I, Kimura W, Fuse A, Suto K, Urayama M (2003) Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 133(5):495–506. doi:10.1067/msy.2003.138

    Article  PubMed  Google Scholar 

  15. Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, Lehmann S, Niehues SM, Schwabe M, Lemke AJ, Neuhaus P (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 250(1):119–125. doi:10.1097/SLA.0b013e3181ad85b5

    Article  PubMed  Google Scholar 

  16. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K (1999) Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188(3):304–309

    Article  CAS  PubMed  Google Scholar 

  17. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137(6):675–680, discussion 680–671

    Article  PubMed  Google Scholar 

  18. Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R (1993) Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 17(1):109–115

    Article  CAS  PubMed  Google Scholar 

  19. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN (2013) Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493–2500

    Article  PubMed  Google Scholar 

  20. de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperin A, Goere D, Elias D, Hechelhammer L (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17(8):2081–2089

    Article  PubMed  Google Scholar 

  21. Nanashima A, Sumida Y, Shibasaki S, Takeshita H, Hidaka S, Sawai T, Shindou H, Abo T, Yasutake T, Nagayasu T, Sakamoto I (2006) Parameters associated with changes in liver volume in patients undergoing portal vein embolization. J Surg Res 133(2):95–101

    Article  CAS  PubMed  Google Scholar 

  22. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA (2006) Platelet-derived serotonin mediates liver regeneration. Science 312(5770):104–107

    Article  CAS  PubMed  Google Scholar 

  23. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    Article  PubMed Central  PubMed  Google Scholar 

  24. Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12(2):139–146. doi:10.1111/j.1477-2574.2009.00151.x

    Article  Google Scholar 

  25. Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR (2008) Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg 143(3):247–253, discussion 253

    Article  CAS  PubMed  Google Scholar 

  26. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, Makuuchi M, Kawasaki S (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29(4):1099–1105

    Article  CAS  PubMed  Google Scholar 

  28. Denys A, Lacombe C, Schneider F, Madoff DC, Doenz F, Qanadli SD, Halkic N, Sauvanet A, Vilgrain V, Schnyder P (2005) Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol: JVIR 16(12):1667–1674. doi:10.1097/01.RVI.0000182183.28547.DC

    Article  PubMed  Google Scholar 

  29. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386–1394. doi:10.1002/bjs.5836

    Article  CAS  PubMed  Google Scholar 

  30. Hoekstra LT, van Lienden KP, Doets A, Busch OR, Gouma DJ, van Gulik TM (2012) Tumor progression after preoperative portal vein embolization. Ann Surg 256(5):812–817, discussion 817–818

    Article  PubMed  Google Scholar 

  31. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200(2):559–563

    Article  CAS  PubMed  Google Scholar 

  32. Hori T, Yagi S, Iida T, Taniguchi K, Yamagiwa K, Yamamoto C, Hasegawa T, Yamakado K, Kato T, Saito K, Wang L, Torii M, Hori Y, Takeda K, Maruyama K, Uemoto S (2007) Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis. World J Gastroenterol 13(44):5918–5925

    Article  PubMed Central  PubMed  Google Scholar 

  33. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol JVIR 16(2 Pt 1):215–225. doi:10.1097/01.RVI.0000147067.79223.85

    Article  Google Scholar 

  34. Yoo H, Ko GY, Gwon DI, Kim JH, Yoon HK, Sung KB, Kim N, Lee J (2009) Preoperative portal vein embolization using an Amplatzer vascular plug. Eur Radiol 19(5):1054–1061. doi:10.1007/s00330-008-1240-2

    Article  PubMed  Google Scholar 

  35. Geisel D, Malinowski M, Powerski MJ, Wustefeld J, Heller V, Denecke T, Stockmann M, Gebauer B (2013) Improved hypertrophy of future remnant liver after portal vein embolization with plugs, coils and particles. Cardiovasc Intervent Radiol. doi:10.1007/s00270-013-0810-0

    PubMed  Google Scholar 

  36. Kusaka K, Imamura H, Tomiya T, Makuuchi M (2004) Factors affecting liver regeneration after right portal vein embolization. Hepatogastroenterology 51(56):532–535

    PubMed  Google Scholar 

  37. de Baere T, Denys A, Paradis V (2009) Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol 19(6):1435–1442. doi:10.1007/s00330-008-1277-2

    Article  PubMed  Google Scholar 

  38. Owen RJ, Mercer JR, Al-Saif F, Molinari M, Ashforth RA, Rajotte RV, Conner-Spady B, Shapiro AM (2009) Portal vein embolization with radiolabeled polyvinyl alcohol particles in a swine model: hepatic distribution and implications for pancreatic islet cell transplantation. Cardiovasc Intervent Radiol 32(3):499–507. doi:10.1007/s00270-009-9544-4

    Article  PubMed  Google Scholar 

  39. Vollmar B, Menger MD (2009) The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89(4):1269–1339. doi:10.1152/physrev.00027.2008

    Article  CAS  PubMed  Google Scholar 

  40. Denys AL, Abehsera M, Leloutre B, Sauvanet A, Vilgrain V, O’Toole D, Belghiti J, Menu Y (2000) Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study. Eur Radiol 10(11):1703–1707

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We greatly appreciate Sina Lehmann, Lina Demirel and Rea Roehl for their help in performing the study.

Conflicts of interest

Martin Stockmann is the inventor of the LiMAx test and has capital interest in Humedics, the company marketing the LiMAx test. Maximilian Jara disclosed receiving research grants in order of the d-LIVER European Commission Framework Programme (www.d-liver.eu). Remaining authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

Authors’ contributions

MM and VS contributed to conception and design of the study, analysed and interpreted data, wrote the manuscript and finally approved the manuscript; JFL, AS, MJ, DS, TD and DG analysed and interpreted data, revised the manuscript and finally approved the manuscript; BG, PN and MS contributed to conception and design of the study, revised the manuscript and finally approved the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maciej Malinowski.

Additional information

Maciej Malinowski and Victoria Stary contributed equally to the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malinowski, M., Stary, V., Lock, J.F. et al. Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization. Langenbecks Arch Surg 400, 237–246 (2015). https://doi.org/10.1007/s00423-014-1266-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-014-1266-7

Keywords

Navigation